查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
安全采血针的全球市场 (2023～2031年):成长、未来展望、竞争分析
市场调查报告书
商品编码
1234374

安全采血针的全球市场 (2023～2031年):成长、未来展望、竞争分析

Safety Lancets Market - Growth, Future Prospects and Competitive Analysis, 2023 - 2031
出版日期: | 出版商: Acute Market Reports | 英文 118 Pages | 商品交期: 最快1-2个工作天内

价格

安全采血针，是单次使用的采血器具。采血针，有处理简单，可不伴随疼痛的静脉穿刺，安全使用等特征，在医院，诊疗所，研究所等广泛使用。由于凝固诊断，糖尿病诊断，HIV筛检，胆固醇监测等，血液学、止血学领域的诊断率提高，安全采血针的利用剧增，预计牵引在预测期间内的全球安全采血针市场。

本报告提供全球安全采血针的市场调查，市场概要，市场成长的各种影响因素分析，市场规模的变化、预测，各种区分、各地区的明细，竞争环境，主要企业简介等彙整资讯。

目录

第1章 序文

第2章 摘要整理

第3章 安全采血针市场:竞争分析

  • 主要供应商的市场定位
  • 供应商的采用策略
  • 主要的产业策略
  • 等级分析

第4章 安全采血针市场:常量分析、市场动态

  • 市场规模的预测
  • 市场动态
    • 推动市场要素
    • 阻碍市场要素
    • 主要课题
    • 主要的机会
  • 促进因素、阻碍因素的影响分析
  • See-Saw分析

第5章 安全采血针市场:各产品

  • 市场概要
  • 成长、收益分析
  • 市场分类
    • 侧面按钮安全采血针
    • 压力工作安全采血针
    • 按钮安全采血针

第6章 安全采血针市场:各终端用户

  • 市场概要
  • 成长、收益分析
  • 市场分类
    • 医院
    • 诊断中心、病理
    • 家庭诊断
    • 其他

第7章 北美的安全采血针市场

第8章 英国及EU的安全采血针市场

第9章 亚太地区的安全采血针市场

第10章 南美的安全采血针市场

第11章 中东、非洲的安全采血针市场

第12章 企业简介

  • F. Hoffmann-La Roche AG
  • Medtronic Public Limited Company
  • Becton
  • Dickinson and Company
  • F.L. MEDICAL SRL
  • Terumo Medical Corporation
  • Haemonetics Corporation
  • Bayer AG
  • Sarstedt AG & Co.
  • Htl-strefa
  • Improve Medical Technology Co. Ltd
  • Amkay Products Pvt. Ltd.
  • B. Braun Melsungen AG
  • Global Surgimed Industries
  • Hicks Thermometers India Ltd.
  • Medline Industries Inc.
  • Sara Healthcare Pvt. Ltd.
  • 其他
Product Code: 138123-01-23

Safety lancets are the single-use blood-sampling device. Needlestick injuries and associated infections are well contained with the use of safety lancets. Lancets are widely used in hospitals, clinics, and laboratories due to certain suitable characteristics, such as easy handling, painless vein puncture, and safe usage. These are available in wide range of designs providing comfortable, secure, and simple puncture. The surge in the utilization of safety lancets due to the increase in diagnosis rate for coagulation, diabetes diagnosis, HIV screening, cholesterol monitoring and other areas of hematology and hemostasis will drive the global safety lancet market during the forecast period.

According to the Leukemia & Lymphoma Society, in 2017, around 172,910 individuals in the United States were expected to be diagnosed with lymphoma and leukemia. Approximately 160 individuals each day die, almost in every 9 minutes, individual dies in the United States due to blood cancer.

As per the records of the Centers for Disease Control and Prevention (CDC), in 2015 around 30.3 million Americans had diabetes, of which 23.1 million were diagnosed. Increase in the occurrence of chronic problems related to kidney function, liver function, heart, and conditions such as rheumatoid arthritis, diabetes, autoimmune disorders, and infection or inflammation will impact the global market for safety lancets.

With various advancements in technology in the home-based healthcare industry, the global safety lancets market will be positively impacted and will witness a lucrative growth. Increase in the utilization of rapid test & point of care (RT & POC) solutions such as blood glucose monitoring devices will drive the global safety lancets market during the forecast period.

Market Dynamic

Drivers

Rising prevalence of infectious diseases and different chronic diseases, along with improved medical device regulations

Rising preference towards home healthcare

Rising prevalence of diabetes

Increasing support of the respective government and healthcare spreading has added fuel to growth of the market.

Opportunities

The regulatory scenario is likely to put positive impacts on the global blood lancet market growth and hence creating opportunities for the same in the near future.

Restraints

The low awareness among individuals regarding homecare lancet in developing economies around the globe is predicted to create hurdles in the growth of the lancet market.

Challenges

The lack of awareness among the developing countries about the homecare usage of safety lancet devices can be considered as the major challenge which ultimately can create a hurdle in the growth of the market.

Key Players Recognized for Safety Lancet Market include:

F. Hoffmann-La Roche AG, Medtronic Public Limited Company, Becton, Dickinson and Company, F.L. MEDICAL SRL, Terumo Medical Corporation, Haemonetics Corporation, Bayer AG, Sarstedt AG & Co., Htl-strefa, Improve Medical Technology Co. Ltd, Amkay Products Pvt. Ltd., B. Braun Melsungen AG, Global Surgimed Industries, Hicks Thermometers India Ltd., Medline Industries Inc., Sara Healthcare Pvt. Ltd. And Others. are a few of the key vendors in the safety lancet market.

Historical & Forecast Period

This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2023 to 2031.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Safety Lancets market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Safety Lancets market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Product

Side Button Safety Lancet

Pressure Activated Safety Lancet

Push Button Safety Lancet

End User

Hospitals

Diagnostic Center & Pathology

Home Diagnostics

Others

Region Segment (2021-2031; US$ Million)

North America

U.S.

Canada

Rest of North America

UK and European Union

UK

Germany

Spain

Italy

France

Rest of Europe

Asia Pacific

China

Japan

India

Australia

South Korea

Rest of Asia Pacific

Latin America

Brazil

Mexico

Rest of Latin America

Middle East and Africa

GCC

Africa

Rest of Middle East and Africa

Global Impact of COVID-19 Segment (2020-2021; US$ Million )

Pre COVID-19 situation

Post COVID-19 situation

Key questions answered in this report:

What are the key micro and macro environmental factors that are impacting the growth of Safety Lancets market?

What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?

Estimated forecast and market projections up to 2031.

Which segment accounts for the fastest CAGR during the forecast period?

Which market segment holds a larger market share and why?

Are low and middle-income economies investing in the Safety Lancets market?

Which is the largest regional market for Safety Lancets market?

What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?

Which are the key trends driving Safety Lancets market growth?

Who are the key competitors and what are their key strategies to enhance their market presence in the Safety Lancets market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Safety Lancets Market
  • 2.2. Global Safety Lancets Market, By Product, 2021 (US$ Million)
  • 2.3. Global Safety Lancets Market, By End User, 2021 (US$ Million)
  • 2.4. Global Safety Lancets Market, By Geography, 2021 (US$ Million)
  • 2.5. Attractive Investment Proposition by Geography, 2021

3. Safety Lancets Market: Competitive Analysis

  • 3.1. Market Positioning of Key Safety Lancets Market Vendors
  • 3.2. Strategies Adopted by Safety Lancets Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2021 Versus 2030

4. Safety Lancets Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Safety Lancets Market Value, 2020 - 2030, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis

5. Safety Lancets Market: By Product, 2020-2030, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2021 Versus 2030
  • 5.3. Market Segmentation
    • 5.3.1. Side Button Safety Lancet
    • 5.3.2. Pressure Activated Safety Lancet
    • 5.3.3. Push Button Safety Lancet

6. Safety Lancets Market: By End User, 2020-2030, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2021 Versus 2030
  • 6.3. Market Segmentation
    • 6.3.1. Hospitals
    • 6.3.2. Diagnostic Center & Pathology
    • 6.3.3. Home Diagnostics
    • 6.3.4. Others

7. North America Safety Lancets Market, 2020-2030, USD (Million)

  • 7.1. Market Overview
  • 7.2. Safety Lancets Market: By Product, 2020-2030, USD (Million)
  • 7.3. Safety Lancets Market: By End User, 2020-2030, USD (Million)
  • 7.4.Safety Lancets Market: By Region, 2020-2030, USD (Million)
    • 7.4.1.North America
      • 7.4.1.1. U.S.
        • 7.4.1.1.1. Safety Lancets Market: By Product, 2020-2030, USD (Million)
        • 7.4.1.1.1. Safety Lancets Market: By End User, 2020-2030, USD (Million)
      • 7.4.1.2. Canada
        • 7.4.1.2.1. Safety Lancets Market: By Product, 2020-2030, USD (Million)
        • 7.4.1.2.1. Safety Lancets Market: By End User, 2020-2030, USD (Million)
      • 7.4.1.3. Rest of North America
        • 7.4.1.3.1. Safety Lancets Market: By Product, 2020-2030, USD (Million)
        • 7.4.1.3.1. Safety Lancets Market: By End User, 2020-2030, USD (Million)

8. UK and European Union Safety Lancets Market, 2020-2030, USD (Million)

  • 8.1. Market Overview
  • 8.2. Safety Lancets Market: By Product, 2020-2030, USD (Million)
  • 8.3. Safety Lancets Market: By End User, 2020-2030, USD (Million)
  • 8.4.Safety Lancets Market: By Region, 2020-2030, USD (Million)
    • 8.4.1.UK and European Union
      • 8.4.1.1. UK
        • 8.4.1.1.1. Safety Lancets Market: By Product, 2020-2030, USD (Million)
        • 8.4.1.1.1. Safety Lancets Market: By End User, 2020-2030, USD (Million)
      • 8.4.1.2. Germany
        • 8.4.1.2.1. Safety Lancets Market: By Product, 2020-2030, USD (Million)
        • 8.4.1.2.1. Safety Lancets Market: By End User, 2020-2030, USD (Million)
      • 8.4.1.3. Spain
        • 8.4.1.3.1. Safety Lancets Market: By Product, 2020-2030, USD (Million)
        • 8.4.1.3.1. Safety Lancets Market: By End User, 2020-2030, USD (Million)
      • 8.4.1.4. Italy
        • 8.4.1.4.1. Safety Lancets Market: By Product, 2020-2030, USD (Million)
        • 8.4.1.4.1. Safety Lancets Market: By End User, 2020-2030, USD (Million)
      • 8.4.1.5. France
        • 8.4.1.5.1. Safety Lancets Market: By Product, 2020-2030, USD (Million)
        • 8.4.1.5.1. Safety Lancets Market: By End User, 2020-2030, USD (Million)
      • 8.4.1.6. Rest of Europe
        • 8.4.1.6.1. Safety Lancets Market: By Product, 2020-2030, USD (Million)
        • 8.4.1.6.1. Safety Lancets Market: By End User, 2020-2030, USD (Million)

9. Asia Pacific Safety Lancets Market, 2020-2030, USD (Million)

  • 9.1. Market Overview
  • 9.2. Safety Lancets Market: By Product, 2020-2030, USD (Million)
  • 9.3. Safety Lancets Market: By End User, 2020-2030, USD (Million)
  • 9.4.Safety Lancets Market: By Region, 2020-2030, USD (Million)
    • 9.4.1.Asia Pacific
      • 9.4.1.1. China
        • 9.4.1.1.1. Safety Lancets Market: By Product, 2020-2030, USD (Million)
        • 9.4.1.1.1. Safety Lancets Market: By End User, 2020-2030, USD (Million)
      • 9.4.1.2. Japan
        • 9.4.1.2.1. Safety Lancets Market: By Product, 2020-2030, USD (Million)
        • 9.4.1.2.1. Safety Lancets Market: By End User, 2020-2030, USD (Million)
      • 9.4.1.3. India
        • 9.4.1.3.1. Safety Lancets Market: By Product, 2020-2030, USD (Million)
        • 9.4.1.3.1. Safety Lancets Market: By End User, 2020-2030, USD (Million)
      • 9.4.1.4. Australia
        • 9.4.1.4.1. Safety Lancets Market: By Product, 2020-2030, USD (Million)
        • 9.4.1.4.1. Safety Lancets Market: By End User, 2020-2030, USD (Million)
      • 9.4.1.5. South Korea
        • 9.4.1.5.1. Safety Lancets Market: By Product, 2020-2030, USD (Million)
        • 9.4.1.5.1. Safety Lancets Market: By End User, 2020-2030, USD (Million)
      • 9.4.1.6. Rest of Asia Pacific
        • 9.4.1.6.1. Safety Lancets Market: By Product, 2020-2030, USD (Million)
        • 9.4.1.6.1. Safety Lancets Market: By End User, 2020-2030, USD (Million)

10. Latin America Safety Lancets Market, 2020-2030, USD (Million)

  • 10.1. Market Overview
  • 10.2. Safety Lancets Market: By Product, 2020-2030, USD (Million)
  • 10.3. Safety Lancets Market: By End User, 2020-2030, USD (Million)
  • 10.4.Safety Lancets Market: By Region, 2020-2030, USD (Million)
    • 10.4.1.Latin America
      • 10.4.1.1. Brazil
        • 10.4.1.1.1. Safety Lancets Market: By Product, 2020-2030, USD (Million)
        • 10.4.1.1.1. Safety Lancets Market: By End User, 2020-2030, USD (Million)
      • 10.4.1.2. Mexico
        • 10.4.1.2.1. Safety Lancets Market: By Product, 2020-2030, USD (Million)
        • 10.4.1.2.1. Safety Lancets Market: By End User, 2020-2030, USD (Million)
      • 10.4.1.3. Rest of Latin America
        • 10.4.1.3.1. Safety Lancets Market: By Product, 2020-2030, USD (Million)
        • 10.4.1.3.1. Safety Lancets Market: By End User, 2020-2030, USD (Million)

11. Middle East and Africa Safety Lancets Market, 2020-2030, USD (Million)

  • 11.1. Market Overview
  • 11.2. Safety Lancets Market: By Product, 2020-2030, USD (Million)
  • 11.3. Safety Lancets Market: By End User, 2020-2030, USD (Million)
  • 11.4.Safety Lancets Market: By Region, 2020-2030, USD (Million)
    • 11.4.1.Middle East and Africa
      • 11.4.1.1. GCC
        • 11.4.1.1.1. Safety Lancets Market: By Product, 2020-2030, USD (Million)
        • 11.4.1.1.1. Safety Lancets Market: By End User, 2020-2030, USD (Million)
      • 11.4.1.2. Africa
        • 11.4.1.2.1. Safety Lancets Market: By Product, 2020-2030, USD (Million)
        • 11.4.1.2.1. Safety Lancets Market: By End User, 2020-2030, USD (Million)
      • 11.4.1.3. Rest of Middle East and Africa
        • 11.4.1.3.1. Safety Lancets Market: By Product, 2020-2030, USD (Million)
        • 11.4.1.3.1. Safety Lancets Market: By End User, 2020-2030, USD (Million)

12. Company Profile

  • 12.1. F. Hoffmann-La Roche AG
    • 12.1.1. Company Overview
    • 12.1.2. Financial Performance
    • 12.1.3. Product Portfolio
    • 12.1.4. Strategic Initiatives
  • 12.2. Medtronic Public Limited Company
    • 12.2.1. Company Overview
    • 12.2.2. Financial Performance
    • 12.2.3. Product Portfolio
    • 12.2.4. Strategic Initiatives
  • 12.3. Becton
    • 12.3.1. Company Overview
    • 12.3.2. Financial Performance
    • 12.3.3. Product Portfolio
    • 12.3.4. Strategic Initiatives
  • 12.4. Dickinson and Company
    • 12.4.1. Company Overview
    • 12.4.2. Financial Performance
    • 12.4.3. Product Portfolio
    • 12.4.4. Strategic Initiatives
  • 12.5. F.L. MEDICAL SRL
    • 12.5.1. Company Overview
    • 12.5.2. Financial Performance
    • 12.5.3. Product Portfolio
    • 12.5.4. Strategic Initiatives
  • 12.6. Terumo Medical Corporation
    • 12.6.1. Company Overview
    • 12.6.2. Financial Performance
    • 12.6.3. Product Portfolio
    • 12.6.4. Strategic Initiatives
  • 12.7. Haemonetics Corporation
    • 12.7.1. Company Overview
    • 12.7.2. Financial Performance
    • 12.7.3. Product Portfolio
    • 12.7.4. Strategic Initiatives
  • 12.8. Bayer AG
    • 12.8.1. Company Overview
    • 12.8.2. Financial Performance
    • 12.8.3. Product Portfolio
    • 12.8.4. Strategic Initiatives
  • 12.9. Sarstedt AG & Co.
    • 12.9.1. Company Overview
    • 12.9.2. Financial Performance
    • 12.9.3. Product Portfolio
    • 12.9.4. Strategic Initiatives
  • 12.10. Htl-strefa
    • 12.10.1. Company Overview
    • 12.10.2. Financial Performance
    • 12.10.3. Product Portfolio
    • 12.10.4. Strategic Initiatives
  • 12.11. Improve Medical Technology Co. Ltd
    • 12.11.1. Company Overview
    • 12.11.2. Financial Performance
    • 12.11.3. Product Portfolio
    • 12.11.4. Strategic Initiatives
  • 12.12. Amkay Products Pvt. Ltd.
    • 12.12.1. Company Overview
    • 12.12.2. Financial Performance
    • 12.12.3. Product Portfolio
    • 12.12.4. Strategic Initiatives
  • 12.13. B. Braun Melsungen AG
    • 12.13.1. Company Overview
    • 12.13.2. Financial Performance
    • 12.13.3. Product Portfolio
    • 12.13.4. Strategic Initiatives
  • 12.14. Global Surgimed Industries
    • 12.14.1. Company Overview
    • 12.14.2. Financial Performance
    • 12.14.3. Product Portfolio
    • 12.14.4. Strategic Initiatives
  • 12.15. Hicks Thermometers India Ltd.
    • 12.15.1. Company Overview
    • 12.15.2. Financial Performance
    • 12.15.3. Product Portfolio
    • 12.15.4. Strategic Initiatives
  • 12.16. Medline Industries Inc.
    • 12.16.1. Company Overview
    • 12.16.2. Financial Performance
    • 12.16.3. Product Portfolio
    • 12.16.4. Strategic Initiatives
  • 12.17. Sara Healthcare Pvt. Ltd.
    • 12.17.1. Company Overview
    • 12.17.2. Financial Performance
    • 12.17.3. Product Portfolio
    • 12.17.4. Strategic Initiatives
  • 12.18. Others
    • 12.18.1. Company Overview
    • 12.18.2. Financial Performance
    • 12.18.3. Product Portfolio
    • 12.18.4. Strategic Initiatives

List of Tables

  • TABLE 1 Global Safety Lancets Market By Product, 2020-2030, USD (Million)
  • TABLE 2 Global Safety Lancets Market By End User, 2020-2030, USD (Million)
  • TABLE 3 North America Safety Lancets Market By Product, 2020-2030, USD (Million)
  • TABLE 4 North America Safety Lancets Market By End User, 2020-2030, USD (Million)
  • TABLE 5 U.S. Safety Lancets Market By Product, 2020-2030, USD (Million)
  • TABLE 6 U.S. Safety Lancets Market By End User, 2020-2030, USD (Million)
  • TABLE 7 Canada Safety Lancets Market By Product, 2020-2030, USD (Million)
  • TABLE 8 Canada Safety Lancets Market By End User, 2020-2030, USD (Million)
  • TABLE 9 Rest of North America Safety Lancets Market By Product, 2020-2030, USD (Million)
  • TABLE 10 Rest of North America Safety Lancets Market By End User, 2020-2030, USD (Million)
  • TABLE 11 UK and European Union Safety Lancets Market By Product, 2020-2030, USD (Million)
  • TABLE 12 UK and European Union Safety Lancets Market By End User, 2020-2030, USD (Million)
  • TABLE 13 UK Safety Lancets Market By Product, 2020-2030, USD (Million)
  • TABLE 14 UK Safety Lancets Market By End User, 2020-2030, USD (Million)
  • TABLE 15 Germany Safety Lancets Market By Product, 2020-2030, USD (Million)
  • TABLE 16 Germany Safety Lancets Market By End User, 2020-2030, USD (Million)
  • TABLE 17 Spain Safety Lancets Market By Product, 2020-2030, USD (Million)
  • TABLE 18 Spain Safety Lancets Market By End User, 2020-2030, USD (Million)
  • TABLE 19 Italy Safety Lancets Market By Product, 2020-2030, USD (Million)
  • TABLE 20 Italy Safety Lancets Market By End User, 2020-2030, USD (Million)
  • TABLE 21 France Safety Lancets Market By Product, 2020-2030, USD (Million)
  • TABLE 22 France Safety Lancets Market By End User, 2020-2030, USD (Million)
  • TABLE 23 Rest of Europe Safety Lancets Market By Product, 2020-2030, USD (Million)
  • TABLE 24 Rest of Europe Safety Lancets Market By End User, 2020-2030, USD (Million)
  • TABLE 25 Asia Safety Lancets Market By Product, 2020-2030, USD (Million)
  • TABLE 26 Asia Safety Lancets Market By End User, 2020-2030, USD (Million)
  • TABLE 27 China Safety Lancets Market By Product, 2020-2030, USD (Million)
  • TABLE 28 China Safety Lancets Market By End User, 2020-2030, USD (Million)
  • TABLE 29 Japan Safety Lancets Market By Product, 2020-2030, USD (Million)
  • TABLE 30 Japan Safety Lancets Market By End User, 2020-2030, USD (Million)
  • TABLE 31 India Safety Lancets Market By Product, 2020-2030, USD (Million)
  • TABLE 32 India Safety Lancets Market By End User, 2020-2030, USD (Million)
  • TABLE 33 Australia Safety Lancets Market By Product, 2020-2030, USD (Million)
  • TABLE 34 Australia Safety Lancets Market By End User, 2020-2030, USD (Million)
  • TABLE 35 South Korea Safety Lancets Market By Product, 2020-2030, USD (Million)
  • TABLE 36 South Korea Safety Lancets Market By End User, 2020-2030, USD (Million)
  • TABLE 37 Latin America Safety Lancets Market By Product, 2020-2030, USD (Million)
  • TABLE 38 Latin America Safety Lancets Market By End User, 2020-2030, USD (Million)
  • TABLE 39 Brazil Safety Lancets Market By Product, 2020-2030, USD (Million)
  • TABLE 40 Brazil Safety Lancets Market By End User, 2020-2030, USD (Million)
  • TABLE 41 Mexico Safety Lancets Market By Product, 2020-2030, USD (Million)
  • TABLE 42 Mexico Safety Lancets Market By End User, 2020-2030, USD (Million)
  • TABLE 43 Rest of Latin America Safety Lancets Market By Product, 2020-2030, USD (Million)
  • TABLE 44 Rest of Latin America Safety Lancets Market By End User, 2020-2030, USD (Million)
  • TABLE 45 Middle East and Africa Safety Lancets Market By Product, 2020-2030, USD (Million)
  • TABLE 46 Middle East and Africa Safety Lancets Market By End User, 2020-2030, USD (Million)
  • TABLE 47 GCC Safety Lancets Market By Product, 2020-2030, USD (Million)
  • TABLE 48 GCC Safety Lancets Market By End User, 2020-2030, USD (Million)
  • TABLE 49 Africa Safety Lancets Market By Product, 2020-2030, USD (Million)
  • TABLE 50 Africa Safety Lancets Market By End User, 2020-2030, USD (Million)
  • TABLE 51 Rest of Middle East and Africa Safety Lancets Market By Product, 2020-2030, USD (Million)
  • TABLE 52 Rest of Middle East and Africa Safety Lancets Market By End User, 2020-2030, USD (Million)

List of Figures

  • FIG. 1 Global Safety Lancets Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Safety Lancets Market: Quality Assurance
  • FIG. 5 Global Safety Lancets Market, By Product, 2021
  • FIG. 6 Global Safety Lancets Market, By End User, 2021
  • FIG. 7 Global Safety Lancets Market, By Geography, 2021
  • FIG. 8 Market Geographical Opportunity Matrix - Global Safety Lancets Market, 2021
  • FIG. 9 Market Positioning of Key Safety Lancets Market Players, 2021
  • FIG. 10 Global Safety Lancets Market - Tier Analysis - Percentage of Revenues by Tier Level, 2021 Versus 2030
  • FIG. 11 Global Safety Lancets Market, By Product, 2021 Vs 2030, %
  • FIG. 12 Global Safety Lancets Market, By End User, 2021 Vs 2030, %
  • FIG. 13 U.S. Safety Lancets Market (US$ Million), 2020 - 2030
  • FIG. 14 Canada Safety Lancets Market (US$ Million), 2020 - 2030
  • FIG. 15 Rest of North America Safety Lancets Market (US$ Million), 2020 - 2030
  • FIG. 16 UK Safety Lancets Market (US$ Million), 2020 - 2030
  • FIG. 17 Germany Safety Lancets Market (US$ Million), 2020 - 2030
  • FIG. 18 Spain Safety Lancets Market (US$ Million), 2020 - 2030
  • FIG. 19 Italy Safety Lancets Market (US$ Million), 2020 - 2030
  • FIG. 20 France Safety Lancets Market (US$ Million), 2020 - 2030
  • FIG. 21 Rest of Europe Safety Lancets Market (US$ Million), 2020 - 2030
  • FIG. 22 China Safety Lancets Market (US$ Million), 2020 - 2030
  • FIG. 23 Japan Safety Lancets Market (US$ Million), 2020 - 2030
  • FIG. 24 India Safety Lancets Market (US$ Million), 2020 - 2030
  • FIG. 25 Australia Safety Lancets Market (US$ Million), 2020 - 2030
  • FIG. 26 South Korea Safety Lancets Market (US$ Million), 2020 - 2030
  • FIG. 27 Rest of Asia Safety Lancets Market (US$ Million), 2020 - 2030
  • FIG. 28 Brazil Safety Lancets Market (US$ Million), 2020 - 2030
  • FIG. 29 Mexico Safety Lancets Market (US$ Million), 2020 - 2030
  • FIG. 30 Rest of Latin America Safety Lancets Market (US$ Million), 2020 - 2030
  • FIG. 31 GCC Safety Lancets Market (US$ Million), 2020 - 2030
  • FIG. 32 Africa Safety Lancets Market (US$ Million), 2020 - 2030
  • FIG. 33 Rest of Middle East and Africa Safety Lancets Market (US$ Million), 2020 - 2030